Emergency contraception market research

Euromonitor has the world’s most comprehensive research on the emergency contraception category within the consumer health industry. We monitor and analyse industry trends around the world, including in-depth data on market share and market size – from the “big picture” qualitative analysis; down to specific category data.

Euromonitor data and market analysis cultivates your organization’s awareness of the emergency contraception market and the greater competitive environment, ensuring accurate and focused strategies for your business.

A resource for your entire organization, Euromonitor market research supports every level of business, assisting in strategic development, marketing, mergers and acquisitions, and brand management.

Our emergency contraception market research answer questions such as:

What is the market size of emergency contraception?
What are the major brands in emergency contraception?
What are the major brands in emergency contraception?
Are emergency contraception products legally available?
What cultural or religious beliefs affect the sales of emergency contraception?

Country Report

Emergency Contraception in Finland

Emergency contraception increased by 3% in current value terms in 2011. Growing sales were the result of greater awareness of the availability of emergency contraception. Some of the 2011 increase was also a result of increased VAT on medicines from ...

May 2012 | US$900| Add to cart | View details ›

Country Report

Emergency Contraception in Slovakia

Emergency contraception grew by 9% in current value terms to reach sales of EUR60,000 in 2011. Escapelle was the only product present at the end of the review period, as it is intended only for exceptional and urgent cases and should not be used as a...

May 2012 | US$900| Add to cart | View details ›

Country Report

Emergency Contraception in Spain

Current value sales of emergency contraception reached a value of EUR7 million in 2011, growing dynamically by 125% in 2011. Although this represents an important growth rate, it is linked to its low base. Nevertheless, the new law on abortion makes ...

May 2012 | US$900| Add to cart | View details ›

Country Report

Emergency Contraception in Latvia

Emergency contraception witnessed sales growth in 2011. The government was not successful in improving the birth rate, which could have affected development of emergency contraception in 2011. The birth rate remained stable and total population was ...

May 2012 | US$900| Add to cart | View details ›

Country Report

Emergency Contraception in South Africa

South Africa remains one of the top countries in Africa where there is serious alcohol consumption amongst teenagers, this trend has led to a general increase in the number of reported cases of unprotected sex amongst young people. Over the past ...

May 2012 | US$900| Add to cart | View details ›

Country Report

Emergency Contraception in the Czech Republic

Some emergency contraception products were switched from Rx to OTC with restriction status at the end of November 2011. OTC with restriction status means that only one pack of emergency contraception can be sold (en bloc) to women over 16 years and ...

Apr 2012 | US$900| Add to cart | View details ›

Country Report

Emergency Contraception in Belarus

A large number of 28-day pack hormonal contraceptive medicines are available in Belarus. However, most consumers in Belarus still believe that hormonal contraceptives, if used frequently, cause side effects, and should only be used under medical ...

Apr 2012 | US$900| Add to cart | View details ›

Country Report

Emergency Contraception in France

Current value sales of emergency contraception grew by 9% in 2011. This growth was relatively similar to but slightly lower than the CAGR observed during the review period. Even if there are some reimbursed RX emergency contraception medicines ...

Apr 2012 | US$900| Add to cart | View details ›

Country Report

Emergency Contraception in the US

In February 2011, global brand owner Teva Pharmaceutical Industries Ltd filed a petition with the FDA to permit the sale of its Plan B One Step over-the-counter. Since 2006, age restrictions on the sale of emergency contraceptives have required that ...

Apr 2012 | US$900| Add to cart | View details ›

Country Report

Emergency Contraception in Russia

All drugs classified as emergency contraception remained Rx in Russia in 2011. The long list of side effects and the hormonal nature of these products prevented regulators from changing their status. These Rx products are known for a wide amount of ...

Mar 2012 | US$900| Add to cart | View details ›